Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07215988

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

This study evaluates the time spent on obtaining insurance approval and drugs, means of insurance coverage, out-of-pocket costs for patients, and the surgical o…

United States70 participantsStarted 2026-02-04

Treatment: Non-Interventional Study

RecruitingPhase 1/2

NCT05269381

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients…

United States132 participantsStarted 2022-03-31

Treatment: Cyclophosphamide, Neoantigen Peptide Vaccine

All recent trials (3 shown)

Active — Not RecruitingPhase 2

NCT03304639

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

This randomized phase II trial studies how well pembrolizumab with or without stereotactic body radiation therapy works in treating patients with Merkel cell ca…

United States9 participantsStarted 2018-06-12

Treatment: Pembrolizumab, Stereotactic Body Radiation Therapy